Tag Archives: ARIA

Top 5 Biotech Stocks To Watch Right Now

The United States is facing an absolutely devastating opioid crisis.

As of September 2017, more than 2 million Americans are dependent on prescription pain pills like opiates, according to CNN.

The number of opioid-related deaths rose 75%, from roughly 20,000 in 2010 to 35,000 in 2015. That means opioid-based drugs kill more than 100 Americans every day.

Never miss a single....More>>>

Best Biotech Stocks To Buy Right Now

Spark Therapeutics (NASDAQ: ONCE) is a primary gene therapy company to address patients suffering from inherited retinal disease (IRD), hemophilia and neurodegenerative diseases. The company presented the cumulative 1-year follow-up Phase 1/2 data of SPK-9001 infusion for the treatment of hemophilia B and preliminary on SPK-8011 Phase 1/2 dose-escalation clinical trial in hemophilia A at the American....More>>>

Top 5 Biotech Stocks To Invest In 2018

Related MRK Agenus Shares Spike Higher Following Mid-Day Upgrade To Buy From Maxim The Stocks That Moved The S&P, Dow And Nasdaq Today The Vetr community has upgraded $MRK to 3.5-Stars. (Vetr)
Related ONVO Add 3D Printing To Your Portfolio With These Stocks Organovo Holdings Sees FY 2016 Revs From Prior....More>>>

Best Biotech Stocks To Buy Right Now

ROTY (Runners of the Year) is a strategy which involves two parts, the official 10 stock model account and our Contenders List of ideas. Basically, we are looking for stocks that could outperform (ideally double or more) within the near to medium term (next quarter to 12 months out). While the majority of these come from the biotech sector due to a high amount of ideal setups, we do have a “go....More>>>

Top Biotech Stocks To Buy Right Now

Shares of Biogen (BIIB) were halted earlier today after the Wall Street Journal reported that Merck (MRK) and Allergan (AGN) are interested in buying the biotech giant. The Journal’s Dana Mattioli, Jonathan Rockoff, and Dana Cimilluca report:

Bloomberg News/Scott Eisen

Biotechnology giant Biogen Inc. has drawn takeover interest from drug companies including Merck & Co. and....More>>>

Top 5 Biotech Stocks To Invest In Right Now

An estimated 36.7 million people around the world have HIV. Around 17 million of them are taking prescription drugs to treat their condition.The total global HIV drug market totals more than $20 billion annually.

There are several choices for investing in HIV drug stocks. Three of the best options for long-term investors are Gilead Sciences (NASDAQ:GILD), GlaxoSmithKline (NYSE:GSK), and Merck....More>>>

Hot Biotech Stocks To Invest In 2018

One blank check company, Capitol Investment Corp. IV, is on the IPO calendar for the week ahead to raise $350 million. The slowdown in IPO activity marks the start of the annual August lull. Aside from the one SPAC, there will likely be no IPOs for the next four weeks.

Quiet periods for four recent IPOs are set to expire next week. Street research is expected on Monday for gene-edited crop....More>>>

Top 10 Biotech Stocks To Watch For 2018

The lull is over. The annual February pause in IPO activity lasted longer than normal, but 2018’s record-breaking start now looks ready to resume. This week IPOs began launching and another billion-dollar IPO joined the pipeline.

One IPO priced this week, the first in almost a month. AI-based biotech BioXcel Therapeutics priced at the low end and finished flat at the offer price. Three....More>>>

Hot Blue Chip Stocks To Invest In Right Now

p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; text-align: justify; font: 13.0px Verdana; -webkit-text-stroke: #000000} span.s1 {font-kerning: none}

Dow 19,000 has a nice ring to it. And the iconic blue chip stock gauge is edging ever closer to that milestone.

After Mondays record-breaking day, when the Dow Jones industrial average, large-company Standard & Poors 500 stock index, tech-dominated....More>>>

Top 10 Biotech Stocks To Buy Right Now

William Patalon III

I learned a lot of things during the three decades I’ve spent watching, chronicling and digging deep into the machinations of the world’s public companies.

And one of the key lessons I learned was also one of the most powerful when it comes to making money.

The lesson: When troubled companies make serious upgrades in their executive ranks,....More>>>